Federal Circuit Finds Method-of-Treatment Claims Including In Vivo Dosing Limitations Are Not Enabled By In Vitro Data

Could European Courts Soon Be Litigating and Enforcing U.S. Patents?

New FDA Guidance Could Speed Biosimilar Approvals and Cut Costs

Polsinelli Life Sciences Spotlight - Volume 2 - Adapting by Design: Navigating Complex Times in Life Sciences

Trump Administration Announces New Executive Order to Promote Domestic Production of Biopharmaceuticals

Judge Connolly (D. Del.) Overturns $96 Million Molecular Diagnostics Jury Verdict, Finds Patents Invalid Under § 112

Federal Circuit Clarifies Rules for Skinny Labeling for Generics and Biosimilar Companies

Patent Basics for Biotech Counsel

Regeneron v Novartis and Vetter: Walker Process Client Update